Literature DB >> 12474225

Uroplakin gene expression in normal human tissues and locally advanced bladder cancer.

Jonathon Olsburgh1, Patricia Harnden, Robert Weeks, Barbara Smith, Adrian Joyce, Geoffrey Hall, Richard Poulsom, Peter Selby, Jennifer Southgate.   

Abstract

The uroplakins are widely regarded as urothelium-specific markers of terminal urothelial cytodifferentiation. This study investigated the expression of the four uroplakin genes, UPIa, UPIb, UPII and UPIII, in a wide range of normal human tissues to determine tissue specificity and in advanced transitional cell carcinoma (TCC) to examine gene expression in primary and metastatic disease. In the urinary tract, all four uroplakins were expressed by urothelium and UPIII was also expressed by prostatic glandular epithelium. UPIa and UPII appeared to be urothelium-specific, but UPIb was detected in several non-urothelial tissues, including the respiratory tract, where it was associated with squamous metaplasia of tracheal and bronchial epithelia. The ten cases of primary TCC and corresponding lymph node metastases demonstrated that each uroplakin gene could be expressed at the mRNA level. No single uroplakin gene was expressed in all primary tumours or metastases, but 80% of the primary tumours and 70% of the lymph node metastases expressed at least one uroplakin gene. UPIII mRNA was often expressed in the absence of UPIII protein. These results confirm that in human tissues the expression of UPIa and UPII genes is highly specific to urothelium and suggest that the tight differentiation-restricted expression of uroplakin genes in normal urothelium is lost following malignant transformation. Copyright 2002 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12474225     DOI: 10.1002/path.1252

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  34 in total

Review 1.  Formation and maintenance of blood-urine barrier in urothelium.

Authors:  Mateja Erdani Kreft; Samo Hudoklin; Kristijan Jezernik; Rok Romih
Journal:  Protoplasma       Date:  2010-06-04       Impact factor: 3.356

2.  Cloning of human uroplakin II gene from Chinese transitional cell carcinoma of bladder and construction of its eukaryotic expression vector.

Authors:  Fangmin Chen; Fuqing Zeng; Qiangsong Tong; Liduan Zheng; Liang Wang; Jihua Dong; Gongcheng Lu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2005

3.  Enhanced expression of EHMT2 is involved in the proliferation of cancer cells through negative regulation of SIAH1.

Authors:  Hyun-Soo Cho; John D Kelly; Shinya Hayami; Gouji Toyokawa; Masahi Takawa; Masanori Yoshimatsu; Tatsuhiko Tsunoda; Helen I Field; David E Neal; Bruce Aj Ponder; Yusuke Nakamura; Ryuji Hamamoto
Journal:  Neoplasia       Date:  2011-08       Impact factor: 5.715

4.  Comprehensively evaluating cis-regulatory variation in the human prostate transcriptome by using gene-level allele-specific expression.

Authors:  Nicholas B Larson; Shannon McDonnell; Amy J French; Zach Fogarty; John Cheville; Sumit Middha; Shaun Riska; Saurabh Baheti; Asha A Nair; Liang Wang; Daniel J Schaid; Stephen N Thibodeau
Journal:  Am J Hum Genet       Date:  2015-05-14       Impact factor: 11.025

5.  Selection of optimal antisense accessible sites of uroplakin II mRNA for bladder urothelium.

Authors:  Liduan Zheng; Qiangsong Tong; Fangmin Chen; Fuqing Zeng; Liang Wang; Jihua Dong
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2009-06-10

6.  Overexpression of the JmjC histone demethylase KDM5B in human carcinogenesis: involvement in the proliferation of cancer cells through the E2F/RB pathway.

Authors:  Shinya Hayami; Masanori Yoshimatsu; Abhimanyu Veerakumarasivam; Motoko Unoki; Yukiko Iwai; Tatsuhiko Tsunoda; Helen I Field; John D Kelly; David E Neal; Hiroki Yamaue; Bruce A J Ponder; Yusuke Nakamura; Ryuji Hamamoto
Journal:  Mol Cancer       Date:  2010-03-13       Impact factor: 27.401

7.  UHRF1 is a novel molecular marker for diagnosis and the prognosis of bladder cancer.

Authors:  M Unoki; J D Kelly; D E Neal; B A J Ponder; Y Nakamura; R Hamamoto
Journal:  Br J Cancer       Date:  2009-06-02       Impact factor: 7.640

8.  Methylation of a CpG island within the uroplakin Ib promoter: a possible mechanism for loss of uroplakin Ib expression in bladder carcinoma.

Authors:  Andrea E Varga; Lefta Leonardos; Paul Jackson; Alexandra Marreiros; Prue A Cowled
Journal:  Neoplasia       Date:  2004 Mar-Apr       Impact factor: 5.715

Review 9.  Uroplakins in urothelial biology, function, and disease.

Authors:  Xue-Ru Wu; Xiang-Peng Kong; Angel Pellicer; Gert Kreibich; Tung-Tien Sun
Journal:  Kidney Int       Date:  2009-04-01       Impact factor: 10.612

10.  Persistent uroplakin expression in advanced urothelial carcinomas: implications in urothelial tumor progression and clinical outcome.

Authors:  Hong-Ying Huang; Shahrokh F Shariat; Tung-Tien Sun; Herbert Lepor; Ellen Shapiro; Jer-Tsong Hsieh; Raheela Ashfaq; Yair Lotan; Xue-Ru Wu
Journal:  Hum Pathol       Date:  2007-08-17       Impact factor: 3.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.